Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.516NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.354NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.162NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.426NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.402NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.424NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.264NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.581NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.330NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.205NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.422NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.56NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.507NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.178NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.273NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.211NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.474NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.297NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.280NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.597NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.443NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.495NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.294NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.453NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.350NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.304NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.315NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used